Seasonal variation of background counting rates in liquid scintillation counting.

A liquid scintillation background sample was measured daily in a custom-built TDCR counter for more than 17 months. The double and triple coincidence counting rates exhibit an annual sinusoidal fluctuation with a maximum in winter and a minimum in summer. Possible correlations with air temperature, air humidity, radon concentration and secondary cosmic radiation were investigated. The observation of a correlation with the ambient dose equivalent rate [Formula: see text] originating from the charged component of secondary cosmic radiation and an anti-correlation with the effective atmospheric temperature Teff suggest that the seasonal fluctuations in the background counting rate may be primarily driven by temporal variations in the muon flux at ground level. Additionally, a correlation was found with the indoor 222Rn concentration in air.

An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics.

BACKGROUND: Personalized molecular radiotherapy based on theragnostics requires accurate quantification of the amount of radiopharmaceutical activity administered to patients both in diagnostic and therapeutic applications. This international multi-center study aims to investigate the clinical measurement accuracy of radionuclide calibrators for 7 radionuclides used in theragnostics: 99mTc, 111In, 123I, 124I, 131I, 177Lu, and 90Y. METHODS: In total, 32 radionuclide calibrators from 8 hospitals located in the Netherlands, Belgium, and Germany were tested. For each radionuclide, a set of four samples comprising two clinical containers (10-mL glass vial and 3-mL syringe) with two filling volumes were measured. The reference value of each sample was determined by two certified radioactivity calibration centers (SCK CEN and JRC) using two secondary standard ionization chambers. The deviation in measured activity with respect to the reference value was determined for each radionuclide and each measurement geometry. In addition, the combined systematic deviation of activity measurements in a theragnostic setting was evaluated for 5 clinically relevant theragnostic pairs: 131I/123I, 131I/124I, 177Lu/111In, 90Y/99mTc, and 90Y/111In. RESULTS: For 99mTc, 131I, and 177Lu, a small minority of measurements were not within ± 5% range from the reference activity (percentage of measurements not within range: 99mTc, 6%; 131I, 14%; 177Lu, 24%) and almost none were outside ± 10% range. However, for 111In, 123I, 124I, and 90Y, more than half of all measurements were not accurate within ± 5% range (111In, 51%; 123I, 83%; 124I, 63%; 90Y, 61%) and not all were within ± 10% margin (111In, 22%; 123I, 35%; 124I, 15%; 90Y, 25%). A large variability in measurement accuracy was observed between radionuclide calibrator systems, type of sample container (vial vs syringe), and source-geometry calibration/correction settings used. Consequently, we observed large combined deviations (percentage deviation > ± 10%) for the investigated theragnostic pairs, in particular for 90Y/111In, 131I/123I, and 90Y/99mTc. CONCLUSIONS: Our study shows that substantial over- or underestimation of therapeutic patient doses is likely to occur in a theragnostic setting due to errors in the assessment of radioactivity with radionuclide calibrators. These findings underline the importance of thorough validation of radionuclide calibrator systems for each clinically relevant radionuclide and sample geometry.

Half-life determination and comparison of activity standards of 231Pa.

The results of an international comparison of activity measurements of a solution of 231Pa are reported and analysed. Prior to this, no known standardisation of 231Pa by activity measurement had been carried out. The comparison was run in 2017-2018 involving eight laboratories, and returned results with no identifiable inconsistencies between methods or laboratories. The results, including one mass determination, gave a231Pa activity concentration of 41.461(48) kBq g-1 and a231Pa atom concentration of 61.48(23) × 1015 atoms g-1, from which a half-life value of 32 570(130) years was derived.

The half-life of 129I.

The radionuclide 129I is a long-lived fission product that decays to 129Xe by beta-particle emission. It is an important tracer in geological and biological processes and is considered one of the most important radionuclides to be assessed in studies of global circulation. It is also one of the major contributors to radiation dose from nuclear waste in a deep geological repository. Its half-life has been obtained by a combination of activity and mass concentration measurements in the frame of a cooperation of 6 European metrology institutes. The value obtained for the half-life of 129I is 16.14 (12) × 106 a, in good agreement with recommended data but with a significant improvement in the uncertainty.

Intercomparison of 99mTc, 18F and 111In activity measurements with radionuclide calibrators in Belgian hospitals.

This study presents current status of performance of radiopharmaceutical activity measurements using radionuclide calibrators in Belgium. An intercomparison exercise was performed among 15 hospitals to test the accuracy of 99mTc, 18F and 111In activity measurements by means of radionuclide calibrators. Four sessions were held in different geographical regions between December 2013 and February 2015. The data set includes measurements from 38 calibrators, yielding 36 calibrations for 99mTc and 111In, and 21 calibrations for 18F. For each radionuclide, 3 ml of stock solution was measured in two clinical geometries: a 10 ml glass vial and a 10 ml syringe. The initial activity was typically 100 MBq for 99mTc, 15 MBq for 111In and 115 MBq for 18F. The reference value for the massic activity of the radioactive solutions was determined by means of primary and secondary standardisation techniques at the radionuclide metrology laboratory of the JRC. The overall results of the intercomparison were satisfactory for 99mTc and 18F, since most radionuclide calibrators (>70%) were accurate within ±5% of the reference value. Nevertheless, some devices underestimated the activity by 10-20%. Conversely, 111In measurements were strongly affected by source geometry effects and this had a negative impact on the accuracy of the measurements, in particular for the syringe sample. Large overestimations (up to 72%) were observed, even when taking into account the corrections and uncertainties supplied by the manufacturers for container effects. The results of this exercise encourage the hospitals to perform corrective actions to improve the calibration of their devices where needed.

Advancements in NORM metrology - Results and impact of the European joint research project MetroNORM.

The results of the three years European Metrology Research Programme's (EMRP) joint research project 'Metrology for processing materials with high natural radioactivity' (MetroNORM) are presented. In this project, metrologically sound novel instruments and procedures for laboratory and in-situ NORM activity measurements have been developed. Additionally, standard reference materials and sources for traceable calibration and improved decay data of natural radionuclides have been established.

On the 209Po half-life error and its confirmation: an answer to the critique.

Pommé et al. published a paper claiming that the 209Po half-life is 20 % higher than the erroneous value of 102 (5) a used for 50 years. Collé and Collé published a critique saying that 'this claim cannot withstand critical scrutiny'. In this work, counterarguments are presented to the critique. The experiment has been continued and a new intermediate half-life value of 122.7 (27) a was obtained. A brief review is made of the 209Po half-life value by Collé et al. and a recommended value of 122.9 (23) a is derived from both experiments.